Heparin-like polymers modulate proinflammatory cytokine production by lipopolysaccharide-stimulated human monocytes

被引:22
作者
Anastase-Ravion, S
Carreno, MP
Blondin, C
Ravion, O
Champion, J
Chaubet, F
Haeffner-Cavaillon, N
Letourneur, D [1 ]
机构
[1] X Bichat Med Sch, INSERM, ERIT M, F-75018 Paris, France
[2] Univ Paris 13, Inst Galilee, LRM, F-93430 Villetaneuse, France
[3] Hop Broussais, INSERM, U430, F-75014 Paris, France
来源
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH | 2002年 / 60卷 / 03期
关键词
cytokine; heparin-like; interleukin; lipopolysaccharide; monocytes;
D O I
10.1002/jbm.10112
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The search for heparin-like materials remains an intensive field of research. In this context, we studied the immunomodulatory properties of semisynthetic dextran derivatives and naturally occurring sulfated polysaccharides present in brown seaweed (fucans). In this study, we investigated the functional potencies of fucan and dextran derivatives by analyzing their effects on the release of proinflammatory cytokines by resting or lipopolysaccharide (LPS)stimulated human monocytes and their interactions on monocyte surfaces. The results showed that fucan, dextran derivatives, and heparin differentially (1) triggered interleukin-let, tumor necrosis factor alpha, interleukin-6, and interleukin-8 production by monocytes in a dose-dependent manner, (2) modulated cytokine production by LPS-stimulated monocytes, and (3) specifically inhibited the binding of biotinylated LPS to monocyte membranes. Taken together, these data indicated that fucan and dextran derivatives displayed interesting immunomodulatory effects on human blood cells that could be relevant as new drugs or biomaterial coatings. Indeed, such polysaccharides, by regulating monocyte activation, could contribute to the improved biocompatibility of implants. (C) 2002 Wiley Periodicals, Inc.
引用
收藏
页码:375 / 383
页数:9
相关论文
共 55 条
[11]   Synthesis and structure-anticoagulant property relationships of functionalized dextrans: CMDBS [J].
Chaubet, F ;
Champion, J ;
Maiga, O ;
Mauray, S ;
Jozefonvicz, J .
CARBOHYDRATE POLYMERS, 1995, 28 (02) :145-152
[12]  
Chaubet F, 1999, POLYM INT, V48, P313, DOI 10.1002/(SICI)1097-0126(199904)48:4<313::AID-PI151>3.0.CO
[13]  
2-H
[14]   A disaccharide repeat unit is the major structure in fucoidans from two species of brown algae [J].
Chevolot, L ;
Mulloy, B ;
Ratiskol, J ;
Foucault, A ;
Colliec-Jouault, S .
CARBOHYDRATE RESEARCH, 2001, 330 (04) :529-535
[15]  
Daniels AU, 2000, J BIOMED MATER RES, V49, P469, DOI 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.0.CO
[16]  
2-A
[17]   EVALUATION OF A TEST SYSTEM FOR MEASURING CYTOKINE PRODUCTION IN HUMAN WHOLE-BLOOD CELL-CULTURES [J].
ELSASSERBEILE, U ;
VONKLEIST, S ;
GALLATI, H .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 139 (02) :191-195
[18]   INITIAL EVALUATION OF HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF SEPSIS SYNDROME - A RANDOMIZED, OPEN-LABEL, PLACEBO-CONTROLLED MULTICENTER TRIAL [J].
FISHER, CJ ;
SLOTMAN, GJ ;
OPAL, SM ;
PRIBBLE, JP ;
BONE, RC ;
EMMANUEL, G ;
NG, D ;
BLOEDOW, DC ;
CATALANO, MA ;
FRIEDMAN, B ;
MURE, A ;
SHAPIRO, E .
CRITICAL CARE MEDICINE, 1994, 22 (01) :12-21
[19]  
GALLAY P, 1993, J IMMUNOL, V150, P5086
[20]   Modulation of human endothelial coil proliferation and migration by fucoidan and heparin [J].
Giraux, JL ;
Matou, S ;
Bros, A ;
Tapon-Bretaudière, J ;
Letourneur, D ;
Fischer, AM .
EUROPEAN JOURNAL OF CELL BIOLOGY, 1998, 77 (04) :352-359